Stock Market News

Obesity drug maker Novo Nordisk's CEO to step down amid market struggle

May 16, 2025 - 12:40
 0
Obesity drug maker Novo Nordisk's CEO to step down amid market struggle
Read More

Tags:

Previous Article

Main Street Capital: Following Up On A Thesis

Next Article

Brazil's Gol secures $ 1.9 billion in exit financing with 5-year term

Related Posts

American Eagle withdraws annual targets, writes down spring, summer inventory

American Eagle withdraws annual targets, writes down sp...

May 13, 2025  0

US House Republicans seek to kill EV tax credit, loan program

US House Republicans seek to kill EV tax credit, loan p...

May 13, 2025  0

May 15, 2025  0